RT @AsBerthomieu: Day 3: Marco Davila's lab tried to optimize CAR-T cell antitumor activity by mutating CD28 subdomains. With Active Motif…
Day 3: Marco Davila's lab tried to optimize CAR-T cell antitumor activity by mutating CD28 subdomains. With Active Motif ATAC-seq and RNA-seq services, they got an overview of the chromatin state and the transcriptome. #transcriptomics #epigenomics https:/
ICYMI: Interested in #CARTcell design? #CD28 mutations can enhance their function by reducing expression of transcription factors and #exhaustion-related genes. @MarcoLDavila #NFAT #NUR77 #TcellRx https://t.co/wbxTgYK57r https://t.co/BIW5T79yH4
Interested in #CARTcell design? #CD28 mutations can enhance their function by reducing expression of transcription factors and #exhaustion-related genes. @MarcoLDavila #NFAT #NUR77 #TcellRx https://t.co/IbaNKOpebF https://t.co/mJszCvZbiD
Lee Moffit/M. Davila's alternative proposal to MSKCC/M. Sadelain's "1XX" ? CD28 Costimulatory Domain–Targeted Mutations Enhance CAR T-cell Function https://t.co/IR8F79sTeM https://t.co/qMRs1jq8Qq
RT @leowanglab: Very cool CAR T CD28 mutagenesis work from the @MarcoLDavila lab @MoffittNews - less appearrs to be more! https://t.co/VUB…
RT @leowanglab: Very cool CAR T CD28 mutagenesis work from the @MarcoLDavila lab @MoffittNews - less appearrs to be more! https://t.co/VUB…
Very cool CAR T CD28 mutagenesis work from the @MarcoLDavila lab @MoffittNews - less appearrs to be more! https://t.co/VUBjsjr6f8
RT @leochicaybam: CAR-T cells with a mutated CD28 domain (only PYAP active) show improved antitumor response, enhanced cytokine production…
CAR-T cells with a mutated CD28 domain (only PYAP active) show improved antitumor response, enhanced cytokine production and decreased exhaustion-related markers #CARTcells #Immunotherapy https://t.co/JQ3jOCDTzs
CD28 co-stimulatory domain-targeted mutations enhance chimeric antigen receptor T-cell function. https://t.co/kgbd3BKnhs
New article: CD28 co-stimulatory domain-targeted mutations enhance chimeric antigen receptor T-cell function. https://t.co/HjCVEOVCwg #melanoma #oncology https://t.co/futSP7B6n0
RT @MarcoLDavila: Happy to share our article just published in @CIR_AACR CD28 co-stimulatory domain-targeted mutations enhance chimeric an…
RT @MarcoLDavila: Happy to share our article just published in @CIR_AACR CD28 co-stimulatory domain-targeted mutations enhance chimeric an…
RT @MarcoLDavila: Happy to share our article just published in @CIR_AACR CD28 co-stimulatory domain-targeted mutations enhance chimeric an…
.@MarcoLDavila is speaking at #SITC2020; read his new paper in #CIR on considerations for #CAR #Tcell design that could improve #Antitumor responses. https://t.co/MAFOvjThpa https://t.co/nNa5CfYxyb
RT @MarcoLDavila: Happy to share our article just published in @CIR_AACR CD28 co-stimulatory domain-targeted mutations enhance chimeric an…
RT @MarcoLDavila: Happy to share our article just published in @CIR_AACR CD28 co-stimulatory domain-targeted mutations enhance chimeric an…
Happy to share our article just published in @CIR_AACR CD28 co-stimulatory domain-targeted mutations enhance chimeric antigen receptor T-cell function https://t.co/86guH9kKQs